Details of the Drug

General Information of Drug (ID: DMJDVCW)

Drug Name
HL-085
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 1/2 [1]
Cross-matching ID
PubChem CID
71621329
TTD ID
DJ8TN2

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
ERK activator kinase (MEK) TTZCRP3 NOUNIPROTAC Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03973151) Study of HL-085 in NRAS Mutant Advanced Melanoma. U.S. National Institutes of Health.
2 Current Development Status of MEK Inhibitors. Molecules. 2017 Sep 26;22(10):1551.